The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Analgesic Creams Market Research Report 2025
Synopsis
Analgesic creams are rubbed into the skin to over painful muscles or joints.
The global Analgesic Creams market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Analgesic Creams is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Analgesic Creams is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Analgesic Creams include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and THE PURE SOURCE, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Analgesic Creams, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Analgesic Creams.
Report Scope
The Analgesic Creams market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Analgesic Creams market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Analgesic Creams manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
THE PURE SOURCE
Mercury Healthcare
Topical BioMedics
Qizheng
Endo
Huarun 999
GSK
Segment by Type
OTC
RX
Segment by Application
Muscle Pain
Arthritis Pain
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Analgesic Creams manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Analgesic Creams in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Analgesic creams are rubbed into the skin to over painful muscles or joints.
The global Analgesic Creams market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Analgesic Creams is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Analgesic Creams is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Analgesic Creams include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and THE PURE SOURCE, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Analgesic Creams, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Analgesic Creams.
Report Scope
The Analgesic Creams market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Analgesic Creams market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Analgesic Creams manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
THE PURE SOURCE
Mercury Healthcare
Topical BioMedics
Qizheng
Endo
Huarun 999
GSK
Segment by Type
OTC
RX
Segment by Application
Muscle Pain
Arthritis Pain
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Analgesic Creams manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Analgesic Creams in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Analgesic Creams Market Overview
1.1 Product Overview and Scope of Analgesic Creams
1.2 Analgesic Creams Segment by Type
1.2.1 Global Analgesic Creams Market Value Comparison by Type (2024-2030)
1.2.2 OTC
1.2.3 RX
1.3 Analgesic Creams Segment by Application
1.3.1 Global Analgesic Creams Market Value by Application: (2024-2030)
1.3.2 Muscle Pain
1.3.3 Arthritis Pain
1.4 Global Analgesic Creams Market Size Estimates and Forecasts
1.4.1 Global Analgesic Creams Revenue 2019-2030
1.4.2 Global Analgesic Creams Sales 2019-2030
1.4.3 Global Analgesic Creams Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Analgesic Creams Market Competition by Manufacturers
2.1 Global Analgesic Creams Sales Market Share by Manufacturers (2019-2024)
2.2 Global Analgesic Creams Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Analgesic Creams Average Price by Manufacturers (2019-2024)
2.4 Global Analgesic Creams Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Analgesic Creams, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Analgesic Creams, Product Type & Application
2.7 Analgesic Creams Market Competitive Situation and Trends
2.7.1 Analgesic Creams Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Analgesic Creams Players Market Share by Revenue
2.7.3 Global Analgesic Creams Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Analgesic Creams Retrospective Market Scenario by Region
3.1 Global Analgesic Creams Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Analgesic Creams Global Analgesic Creams Sales by Region: 2019-2030
3.2.1 Global Analgesic Creams Sales by Region: 2019-2024
3.2.2 Global Analgesic Creams Sales by Region: 2025-2030
3.3 Global Analgesic Creams Global Analgesic Creams Revenue by Region: 2019-2030
3.3.1 Global Analgesic Creams Revenue by Region: 2019-2024
3.3.2 Global Analgesic Creams Revenue by Region: 2025-2030
3.4 North America Analgesic Creams Market Facts & Figures by Country
3.4.1 North America Analgesic Creams Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Analgesic Creams Sales by Country (2019-2030)
3.4.3 North America Analgesic Creams Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Analgesic Creams Market Facts & Figures by Country
3.5.1 Europe Analgesic Creams Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Analgesic Creams Sales by Country (2019-2030)
3.5.3 Europe Analgesic Creams Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Analgesic Creams Market Facts & Figures by Country
3.6.1 Asia Pacific Analgesic Creams Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Analgesic Creams Sales by Country (2019-2030)
3.6.3 Asia Pacific Analgesic Creams Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Analgesic Creams Market Facts & Figures by Country
3.7.1 Latin America Analgesic Creams Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Analgesic Creams Sales by Country (2019-2030)
3.7.3 Latin America Analgesic Creams Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Analgesic Creams Market Facts & Figures by Country
3.8.1 Middle East and Africa Analgesic Creams Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Analgesic Creams Sales by Country (2019-2030)
3.8.3 Middle East and Africa Analgesic Creams Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Analgesic Creams Sales by Type (2019-2030)
4.1.1 Global Analgesic Creams Sales by Type (2019-2024)
4.1.2 Global Analgesic Creams Sales by Type (2025-2030)
4.1.3 Global Analgesic Creams Sales Market Share by Type (2019-2030)
4.2 Global Analgesic Creams Revenue by Type (2019-2030)
4.2.1 Global Analgesic Creams Revenue by Type (2019-2024)
4.2.2 Global Analgesic Creams Revenue by Type (2025-2030)
4.2.3 Global Analgesic Creams Revenue Market Share by Type (2019-2030)
4.3 Global Analgesic Creams Price by Type (2019-2030)
5 Segment by Application
5.1 Global Analgesic Creams Sales by Application (2019-2030)
5.1.1 Global Analgesic Creams Sales by Application (2019-2024)
5.1.2 Global Analgesic Creams Sales by Application (2025-2030)
5.1.3 Global Analgesic Creams Sales Market Share by Application (2019-2030)
5.2 Global Analgesic Creams Revenue by Application (2019-2030)
5.2.1 Global Analgesic Creams Revenue by Application (2019-2024)
5.2.2 Global Analgesic Creams Revenue by Application (2025-2030)
5.2.3 Global Analgesic Creams Revenue Market Share by Application (2019-2030)
5.3 Global Analgesic Creams Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Corporation Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisamitsu Analgesic Creams Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Analgesic Creams Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Analgesic Creams Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Corporation Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Actavis Analgesic Creams Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Lingrui
6.5.1 Lingrui Corporation Information
6.5.2 Lingrui Description and Business Overview
6.5.3 Lingrui Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lingrui Analgesic Creams Product Portfolio
6.5.5 Lingrui Recent Developments/Updates
6.6 Teikoku Seiyaku
6.6.1 Teikoku Seiyaku Corporation Information
6.6.2 Teikoku Seiyaku Description and Business Overview
6.6.3 Teikoku Seiyaku Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teikoku Seiyaku Analgesic Creams Product Portfolio
6.6.5 Teikoku Seiyaku Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Analgesic Creams Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novartis Analgesic Creams Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 THE PURE SOURCE
6.9.1 THE PURE SOURCE Corporation Information
6.9.2 THE PURE SOURCE Description and Business Overview
6.9.3 THE PURE SOURCE Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.9.4 THE PURE SOURCE Analgesic Creams Product Portfolio
6.9.5 THE PURE SOURCE Recent Developments/Updates
6.10 Mercury Healthcare
6.10.1 Mercury Healthcare Corporation Information
6.10.2 Mercury Healthcare Description and Business Overview
6.10.3 Mercury Healthcare Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mercury Healthcare Analgesic Creams Product Portfolio
6.10.5 Mercury Healthcare Recent Developments/Updates
6.11 Topical BioMedics
6.11.1 Topical BioMedics Corporation Information
6.11.2 Topical BioMedics Analgesic Creams Description and Business Overview
6.11.3 Topical BioMedics Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Topical BioMedics Analgesic Creams Product Portfolio
6.11.5 Topical BioMedics Recent Developments/Updates
6.12 Qizheng
6.12.1 Qizheng Corporation Information
6.12.2 Qizheng Analgesic Creams Description and Business Overview
6.12.3 Qizheng Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Qizheng Analgesic Creams Product Portfolio
6.12.5 Qizheng Recent Developments/Updates
6.13 Endo
6.13.1 Endo Corporation Information
6.13.2 Endo Analgesic Creams Description and Business Overview
6.13.3 Endo Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Endo Analgesic Creams Product Portfolio
6.13.5 Endo Recent Developments/Updates
6.14 Huarun 999
6.14.1 Huarun 999 Corporation Information
6.14.2 Huarun 999 Analgesic Creams Description and Business Overview
6.14.3 Huarun 999 Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Huarun 999 Analgesic Creams Product Portfolio
6.14.5 Huarun 999 Recent Developments/Updates
6.15 GSK
6.15.1 GSK Corporation Information
6.15.2 GSK Analgesic Creams Description and Business Overview
6.15.3 GSK Analgesic Creams Sales, Revenue and Gross Margin (2019-2024)
6.15.4 GSK Analgesic Creams Product Portfolio
6.15.5 GSK Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Analgesic Creams Industry Chain Analysis
7.2 Analgesic Creams Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Analgesic Creams Production Mode & Process
7.4 Analgesic Creams Sales and Marketing
7.4.1 Analgesic Creams Sales Channels
7.4.2 Analgesic Creams Distributors
7.5 Analgesic Creams Customers
8 Analgesic Creams Market Dynamics
8.1 Analgesic Creams Industry Trends
8.2 Analgesic Creams Market Drivers
8.3 Analgesic Creams Market Challenges
8.4 Analgesic Creams Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
